[1] HOFMANN H, VANWALSCAPPEL B, BLOCH N, et al. TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes[J].Retrovirology, 2016, 13(1):83. [2] RYOO J, CHOI J, OH C, et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction[J]. Nat Med, 2014, 20(8):936-941. [3] LIN,ZHANG W,CAO X.Indenfification of human homologue of mouse IFN-gamma induced protein from human dendritic cells[J]. Immunol Lett,2000,74(3):221-224. [4] RICE GVI, BOND J, ASIPU A, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response[J]. Nat Genet, 2009, 41(7):829-832. [5] LAQUETE N, SOBHIAN B, CASARTELLI N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx[J]. Nature, 2011, 474(7353):654-657. [6] GOLDSTONE D C, ENNIS-ADENRIAN V, HEDDEN J J, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase[J]. Nature, 2011, 480(7377):379-382. [7] BALDAUF H M, PAN X, ERIKSON E, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells[J]. Nat Med, 2012, 18(11):1682-1687. [8] DESCOURS B, CRIBIER A, CHABLE-BESSIA C, et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells[J]. Retrovirology, 2012, 9:87. [9] WEI W, GUO H, HAN X, et al. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest[J]. Cell Microbiol, 2012, 14(11):1745-1756. [10] HRECKA K, HAO C, GIERSZEWSKA M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein[J]. Nature, 2011, 474(7353):658-661. [11] GUO H, WEI W, WEI Z, et al. Identification of critical regions in human SAMHD1 required for nuclear localization and Vpx-mediated degradation[J]. PLoS One, 2013, 8(7):e66201. [12] WEI W, GUO H, LIU X, et al. A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation[J]. J Virol, 2014, 88(1):745-751. [13] HOLLENBAUGH J A, GEE P, BAKER J, et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells[J]. PLoS Pathog, 2013, 9(6):e1003481. [14] HU J, QIAO M, CHEN Y, et al. Cyclin E2-CDK2 mediates SAMHD1 phosphorylation to abrogate its restriction of HBV replication in hepatoma cells[J]. FEBS Lett, 2018, 592(1):1893-1904. [15] CABELLO-LOBATO M J, WANG S, SCHMID C K, et al. SAMHD1 sheds moonlight on DNA double-strand break repair[J]. Trends Genet, 2017, 33(12):895. [16] COQUEL F, SILVA M J, TECHER H, et al. SAMHD1 acts at stalled replication forks to prevent interferon induction[J]. Nature, 2018, 557(7703):57-61. [17] ZHAO K, DU J, HAN X, et al. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutieres syndrome-related SAMHD1[J]. Cell Rep, 2013, 4(6):1108-1115. [18] WHITE T E, BRANDARIZ-NUNEZ, HAN K, et al. Modulation of LINE-1 retrotransposition by a human SAMHD1 polymorphism[J]. Virol Rep, 2016, 6:53-60. [19] MAELFAIT J, BRIDGEMAN A, BENLAHRECH A, et al. Restriction by SAMHD1 Limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1[J]. Cell Rep, 2016, 16(6), 1492-1501. [20] CHEN S, BONIFATI S, QIN Z, et al. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways[J]. Proc Natl Acad Sci, 2018, 115(16):E3798-E3807. [21] WEI W, GUO H, GAO Q, et al. Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins[J]. J Virol, 2014, 88(1):583-591. [22] LIM E S, FREGOSO O I, MCCOY C O, et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx[J]. Cell Host Microbe, 2012, 11(2):194-204. [23] CRIBIER A, DESCOURS B, VALADAO A L, et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1[J]. Cell Rep, 2013, 3(4):1036-1043. [24] WANG Z, BHATTACHARYA A, WHITE T, et al. Functionality of redox-active cysteines is required for restriction of retroviral replication by SAMHD1[J]. Cell Rep, 2018, 24(4):815-823. [25] WHITE T E, BRANDARIZ-NUNEZ A, VALLE-CASUSO J C, et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation[J]. Cell Host Microbe, 2013, 13(4):441-451. [26] WEI W, GUO H, GAO Q, et al. Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins[J]. J Virol, 2014, 88(1):583-591. [27] WANG JL, LU F Z, SHEN X Y, et al. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation[J]. Biochem Biophys Res Commun, 2014, 455(3/4):229-233. [28] CLIFFORD R, LOUIS T, ROBBE P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage[J]. Blood, 2014, 123(7):1021-1031. [29] WHITE T E, BRANDARIZ-NUNEZ A, MARTINEZ-LOPEZ A, et al. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type Ⅰ interferon in humans[J]. Hum Mutat, 2017, 38(6):658-668. [30] MAELFAIT J, BRIDGEMAN A, BENLAHRECH A, et al. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1[J]. Cell Rep, 2016, 16(6):1492-1501. |